Quinazolinone–diarylpyrazole hybrids as dual EGFR/COX-2 inhibitors: antiproliferative, mechanistic, and <i>in silico</i> studies
- DOI
- 10.1039/d6ra07867b
- Published
- 2026
- Container
- RSC Advances
- Publisher
- Royal Society of Chemistry (RSC)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1039/d6ra07867b,
title = {Quinazolinone–diarylpyrazole hybrids as dual EGFR/COX-2 inhibitors: antiproliferative, mechanistic, and
<i>in silico</i>
studies},
author = {Abdullah Alkhammash and Basima A. A. Saleem and Khulood H. Oudah and Mohamed Ahmed and Kasim Sakran Abass and Sara Mahmoud Farhan and Magdi E. A. Zaki and Sobhi M. Gomha},
year = {2026},
journal = {RSC Advances},
doi = {10.1039/d6ra07867b},
url = {https://doi.org/10.1039/d6ra07867b}
}RIS
TY - JOUR
TI - Quinazolinone–diarylpyrazole hybrids as dual EGFR/COX-2 inhibitors: antiproliferative, mechanistic, and
<i>in silico</i>
studies
AU - Abdullah Alkhammash
AU - Basima A. A. Saleem
AU - Khulood H. Oudah
AU - Mohamed Ahmed
AU - Kasim Sakran Abass
AU - Sara Mahmoud Farhan
AU - Magdi E. A. Zaki
AU - Sobhi M. Gomha
PY - 2026
JO - RSC Advances
DO - 10.1039/d6ra07867b
UR - https://doi.org/10.1039/d6ra07867b
ER - APA
Alkhammash, A., Saleem, B. A. A., Oudah, K. H., Ahmed, M., Abass, K. S., Farhan, S. M., Zaki, M. E. A., & Gomha, S. M. (2026). Quinazolinone–diarylpyrazole hybrids as dual EGFR/COX-2 inhibitors: antiproliferative, mechanistic, and <i>in silico</i> studies. RSC Advances. https://doi.org/10.1039/d6ra07867b
Source records
- crossref · retrieved 2026-09-26T12:48:35.326Z